Investigators

Summary

The research in the laboratory of Dr. Fernandez focuses on improving cancer treatment and patient outcomes through various areas:

1. Investigating drug-induced immunogenicity and liver injury.
2. Developing targeted agents for acute lymphoblastic leukemia.
3. Preventing capecitabine-induced hand-foot syndrome.
4. Studying the role of the NFAT transcription factor on immune cells.

The Fernandez lab aims to enhance treatment outcomes by understanding complex biological processes using pharmacogenomic approaches. Our work includes addressing the immunogenicity of protein-based therapeutics, studying drug-induced liver injury linked to chemotherapy, and personalizing treatments for acute lymphoblastic leukemias. Ultimately, our translational research strives to reveal underlying mechanisms, identify druggable targets, and bridge bench work with clinical practice.